editorial | Q871232 |
scholarly article | Q13442814 |
P2093 | author name string | Jong Eun Yeon | |
P2860 | cites work | Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study | Q57213193 |
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C | Q58788714 | ||
EASL Recommendations on Treatment of Hepatitis C 2018 | Q88344766 | ||
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options | Q29620126 | ||
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus | Q34044333 | ||
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. | Q37352305 | ||
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study | Q38795446 | ||
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study | Q39599901 | ||
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus | Q40007121 | ||
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience. | Q40411310 | ||
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. | Q41066364 | ||
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial | Q41750256 | ||
Sofosbuvir and ribavirin in HCV genotypes 2 and 3. | Q42220605 | ||
Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans | Q42989632 | ||
Sofosbuvir for previously untreated chronic hepatitis C infection | Q42995119 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular biology | Q7202 |
ribavirin | Q421862 | ||
sofosbuvir | Q2502747 | ||
chronic hepatitis C | Q55779873 | ||
P304 | page(s) | 294-296 | |
P577 | publication date | 2018-09-01 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans? | |
P478 | volume | 24 |
Search more.